Early identification and management decreases hyperglycemia, hospital-acquired infections

Obstructive sleep apnea, but not SSD, is linked to obesity, hypertension, and dyslipidemia

Rising costs of insulin causing patients to ration their doses or even do without the drug

This week our medical editor, Joy Pape, was faced with patient questions on the contaminated ARB’s, that many of you have also gotten. She had been on the front side of the valsartan problem and was changing her patients to losartan, only to have to call them back. Check out …

This may not be an actual “physical” disaster averted yet because we don’t know the long-term effects on the people who have taken the ARBs and possibly other medications that were tainted with carcinogens or other “poisons.” When we (health care providers) were first notified of this issue, my first …

Intensive diabetes therapy can be associated with excess weight gain, central obesity, and dyslipidemia with increased heart disease risk.

Addition of bolus insulin to avoid overbasalization is key.

Specific A1c, glucose ranges associated with diabetes-specific vision impairment.

Nancy J. D'Hondt  RPh, CDE, FAADE is a past president of the American Association of Diabetes Educators. She is a staff/clinical pharmacist in a 600-bed facility and is responsible for the review and processing of medication orders, patient-controlled analgesia, ADR and DUR monitoring, pharmacokinetic dosing, anticoagulation, and multidisciplinary rounds. Nancy specializes in diabetes care and self-management support for both the inpatient and outpatient populations, providing expertise on protocol development and implementation, staff education, and formulary decisions.

Genetic evidence shows elevated SHBG levels may protect against asthma, mostly in females